FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 308:302-307 February 10, 1983 Number 6 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

One hundred thirty patients with severe aplastic anemia were conditioned with cyclophosphamide for transplantation of marrow from HLA-identical siblings. The patients were selected for the present analysis according to the criterion of sustained marrow engraftment. Of the 130 patients, 97 are now alive between 1.4 and 11 years (median, 5) after transplantation. Twenty-nine of the thirty-three who died had either acute or chronic graft-versus-host disease (GVHD). Our analysis was directed at identifying factors predicting GVHD and survival after transplantation in patients. Our key findings were that moderately severe to severe acute GVHD had a strong adverse influence on survival; that a protective environment significantly reduced mortality, which corresponded in part to a reduction in and delayed onset of acute GVHD; that refractoriness to random-donor platelet infusions at transplantation adversely influenced survival, particularly among patients with acute GVHD; and that increasing age was associated with increased mortality.

This article has been cited by other articles:

• Hahn, T., McCarthy, P. L. Jr, Zhang, M.-J., Wang, D., Arora, M., Frangoul, H., Gale, R. P., Hale, G. A., Horan, J., Isola, L., Maziarz, R. T., van Rood, J. J., Gupta, V., Halter, J., Reddy, V., Tiberghien, P., Litzow, M., Anasetti, C., Pavletic, S., Ringden, O. (2008). Risk Factors for Acute Graft-Versus-Host Disease After Human Leukocyte Antigen-Identical Sibling Transplants for Adults With Leukemia. JCO 26: 5728-5734 [Abstract] [Full Text]  
• Baron, F., Maris, M. B., Sandmaier, B. M., Storer, B. E., Sorror, M., Diaconescu, R., Woolfrey, A. E., Chauncey, T. R., Flowers, M. E.D., Mielcarek, M., Maloney, D. G., Storb, R. (2005). Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning. JCO 23: 1993-2003 [Abstract] [Full Text]  
• Iwasaki, T. (2004). Recent Advances in the Treatment of Graft-Versus-Host Disease. Clin Med Res 2: 243-252 [Abstract] [Full Text]  
• Storb, R. F., Lucarelli, G., McSweeney, P. A., Childs, R. W. (2003). Hematopoietic Cell Transplantation for Benign Hematological Disorders and Solid Tumors. ASH Education Book 2003: 372-397 [Abstract] [Full Text]  
• Svahn, B.-M., Remberger, M., Myrback, K.-E., Holmberg, K., Eriksson, B., Hentschke, P., Aschan, J., Barkholt, L., Ringden, O. (2002). Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood 100: 4317-4324 [Abstract] [Full Text]  
• Cooke, K. R., Olkiewicz, K., Erickson, N., Ferrara, J. L.M. (2002). The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. Innate Immunity 8: 441-448 [Abstract]  
• Tabbara, I. A., Zimmerman, K., Morgan, C., Nahleh, Z. (2002). Allogeneic Hematopoietic Stem Cell Transplantation: Complications and Results. Arch Intern Med 162: 1558-1566 [Abstract] [Full Text]  
• Urbano-Ispizua, A., Rozman, C., Pimentel, P., Solano, C., de la Rubia, J., Brunet, S., Perez-Oteyza, J., Ferra, C., Zuazu, J., Caballero, D., Bargay, J., Carvalhais, A., Diez, J. L., Espigado, I., Alegre, A., Rovira, M., Campilho, F., Odriozola, J., Sanz, M. A., Sierra, J., Garcia-Conde, J., Montserrat, E. (2002). Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings. Blood 100: 724-727 [Abstract] [Full Text]  
• Flanagan, D. L., Gross, R., Jennings, C. D., Caywood, B. E., Goes, S., Kaplan, A. M., Bryson, J. S. (2001). Induction of syngeneic graft-versus-host disease in LPS hyporesponsive C3H/HeJ mice. J. Leukoc. Biol. 70: 873-880 [Abstract] [Full Text]  
• Sullivan, K. M., Dykewicz, C. A., Longworth, D. L., Boeckh, M., Baden, L. R., Rubin, R. H., Sepkowitz, K. A. (2001). Preventing Opportunistic Infections After Hematopoietic Stem Cell Transplantation: The Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and Beyond. ASH Education Book 2001: 392-421 [Abstract] [Full Text]  
• Zhou, Y., Barnett, M. J., Rivers, J. K. (2000). Clinical Significance of Skin Biopsies in the Diagnosis and Management of Graft-vs-Host Disease in Early Postallogeneic Bone Marrow Transplantation. Arch Dermatol 136: 717-721 [Abstract] [Full Text]  
• Hill, G. R., Ferrara, J. L. M. (2000). The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 95: 2754-2759 [Abstract] [Full Text]  
• Rapoport, A. P., Miller Watelet, L. F., Linder, T., Eberly, S., Raubertas, R. F., Lipp, J., Duerst, R., Abboud, C. N., Constine, L., Andrews, J., Etter, M. A., Spear, L., Powley, E., Packman, C. H., Rowe, J. M., Schwertschlag, U., Bedrosian, C., Liesveld, J. L. (1999). Analysis of Factors That Correlate With Mucositis in Recipients of Autologous and Allogeneic Stem-Cell Transplants. JCO 17: 2446-2446 [Abstract] [Full Text]  
• Appelbaum, F. R. (1999). Choosing the Source of Stem Cells for Allogeneic Transplantation: No Longer a Peripheral Issue. Blood 94: 381-383 [Full Text]  
• Beelen, D. W., Elmaagacli, A., Muller, K.-D., Hirche, H., Schaefer, U. W. (1999). Influence of Intestinal Bacterial Decontamination Using Metronidazole and Ciprofloxacin or Ciprofloxacin Alone on the Development of Acute Graft-Versus-Host Disease After Marrow Transplantation in Patients With Hematologic Malignancies: Final Results and Long-Term Follow-Up of an Open-Label Prospective Randomized Trial. Blood 93: 3267-3275 [Abstract] [Full Text]  
• Aractingi, S., Chosidow, O. (1998). Cutaneous Graft-versus-Host Disease. Arch Dermatol 134: 602-612 [Abstract] [Full Text]  
• Hill, G. R., Crawford, J. M., Cooke, K. R., Brinson, Y. S., Pan, L., Ferrara, J. L.M. (1997). Total Body Irradiation and Acute Graft-Versus-Host Disease: The Role of Gastrointestinal Damage and Inflammatory Cytokines. Blood 90: 3204-3213 [Abstract] [Full Text]  
• Passweg, J. R., Socie, G., Hinterberger, W., Bacigalupo, A., Biggs, J. C., Camitta, B. M., Champlin, R. E., Gale, R. P., Gluckman, E., Gordon-Smith, E. C., Hows, J. M., Klein, J. P., Nugent, M. L., Pasquini, R., Rowlings, P. A., Speck, B., Tichelli, A., Zhang, M.-J., Horowitz, M. M., Bortin, M. M. (1997). Bone Marrow Transplantation for Severe Aplastic Anemia: Has Outcome Improved?. Blood 90: 858-864 [Abstract] [Full Text]  
• Woo, S.-B., Lee, S. J., Schubert, M. M. (1997). Graft-vs.-Host Disease. CROBM 8: 201-216 [Abstract] [Full Text]  
• Ferrara, J., Cooke, K., Pan, L, Krenger, W (1996). The immunopathophysiology of acute graft-versus-host-disease. Stem Cells 14: 473-489 [Abstract]  
• Quaglini, S., Bellazzi, R., Locatelli, F., Stefanelli, M., Salvaneschi, C. (1994). An Influence Diagram for Assessing GVHD Prophylaxis after Bone Marrow Transplantation in Children. Med Decis Making 14: 223-235 [Abstract]  
• Mayumi, H., Matsui, K., Matsuzaki, K., Uchida, T., Shinozaki, K., Tokunaga, K. (1994). Cellular kinetics of posttransfusion graft-versus-host disease after heart operations. J. Thorac. Cardiovasc. Surg. 108: 179-182 [Full Text]  
• Shannon, K. M., Cowan, M. J., Matthay, K. K. (1987). Pediatric Bone Marrow Transplantation: Intensive Care Management. J Intensive Care Med 2: 328-344 [Abstract]